Fast Food Indonesia Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? Fast Food Indonesia Tbk. trades at Rp440 (market cap 2.02T, 5.71M 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Fast Food Indonesia Tbk. is far larger — about 19.3× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| FAST | SCPI | |
|---|---|---|
Market Cap | 2.02T | 104.4B |
Volume | 5.71M | — |
Lot | 57.09K | — |
Turnover | 2.52B | — |
Average Price | 441.35 | — |
Value | 2.52B | — |
Indicative Equilibrium Price | 440 | — |
Indicative Equilibrium Volume | 1.11K | — |
Trailing returns across standard periods
Latest headlines on both assets
PT. Fast Food Indonesia Tbk is a company founded in 1978 by the Gelael Group and the exclusive KFC franchise holder in Indonesia. The first KFC outlet opened in October 1979 at Jl. Melawai, Jakarta proved to be successful and paved the way for the opening of more additional outlets in Jakarta. The Company expanded its regional coverage to include other major cities in Indonesia and because of its success in building KFC brand image for the past 20 years of operation, KFC became the country’s dominant fast food market leader.
Read more on FAST →PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →